.: The McLaughlin Endowment » Committee Members : .

Home » Committee Members

McLaughlin Committee Member List — September 1, 2012 – August 31, 2013

Name	Department	Ext.	Dates	Email
Antonella Casola, MD	Pediatric Infectious Diseases	70581	2012-Present	ancasola@utmb.edu
Thomas Geisbert, PhD	Microbiology & Immunology	66906	2011-Present	twgeisbe@utmb.edu
Jere McBride, PhD	Pathology	72498	2010-Present	jemcbrid@utmb.edu
Andrew McNees, PhD	Assistant Director, Institute for Human Infections and Immunity	66500	ex officio	amcnees@utmb.edu
Peter C Melby, MD, Committee Chair	Internal Medicine/Infectious Diseases	71910	2010-Present	pcmelby@utmb.edu
Gregg Milligan, PhD	Pediatrics / Microbiology & Immunology	78145	2011-Present	gnmillig@utmb.edu
Frederick A Murphy, DVM, PhD	Pathology	72430	2005-Present	famurphy@utmb.edu
David W. Niesel, PhD	Chair, Microbiology & Immunology Vice Dean, GSBS	22324	ex officio	dniesel@utmb.edu
Slobodan Paessler, DVM, PhD	Pathology	66913	2012-Present	slpaessl@utmb.edu
Tian Wang, PhD	Microbiology & Immunology	23146	2012-Present	ti1wang@utmb.edu
Scott Weaver, PhD	Director, Institute for Human Infections and Immunity	66500	ex officio	sweaver@utmb.edu

The McLaughlin Committee is comprised of at least seven faculty members of the School of Medicine at UTMB that hold the rank of Assistant Professor or higher. In addition, there are ex officio committee members representing the Graduate School of Biomedical Sciences and the Institute for Human Infections & Immunity (IHII). The Director of the IHII appoints members of the Committee and the Chairperson. The terms of committee members are generally two years, except the Chairperson who serves at the call of the Director of the Institute for Human Infections and Immunity. Outoing Chairs remain on the Committee as full voting members for an additional year after their term ends to help with Chair succession.

The McLaughlin Committee has responsibility for managing the predoctoral and postdoctoral fellowship programs supported by the endowment, and serves in an advisory capacity to the Director of the Institute for Human Infections & Immunity and the President of the University of Texas Medical Branch.